Telepatia
AI clinical platform built for Latin America, and the first vendor in this index whose primary market is outside the United States and Europe. The platform combines ambient documentation, clinical decision support, and EHR integration: it transcribes consultations in real time and generates structured records adapted to each clinician's style, reviews the record, flags potential errors, and surfaces evidence based recommendations and institutional protocol guidance during the encounter. Models are trained on clinical guidelines, peer reviewed literature, and local institutional protocols, which is the substantive localization claim rather than translation alone. Since launching July 2025 the company reports deployment across more than 25 hospital systems in Brazil, Colombia, and Mexico, reaching 14 million patients and processing over 5 million consultations. Reported outcomes at customer sites include protocol adherence rising from 84 percent to 99 percent, physicians recovering roughly 1.7 to 2 hours daily, and 60,000 medical errors flagged in real time. Mater Dei in Brazil reports physicians using the platform around eight hours a day. A free tier targets independent private practice physicians who lack institutional technology access. The company positions the product as supporting clinicians rather than deciding, with the physician making the final call, and is operating while AI regulation is still forming regionally: Brazil's Senate has approved a risk based AI bill pending further approval, and Colombia has sent its own bill to Congress. Founded by Nicolas Abad after his father, a physician, died from a preventable drug interaction. $42 million raised including a $33 million Series A led by Andreessen Horowitz.
Capability Axes
Built AI native from launch in July 2025 rather than adding models to existing software, which the company and its investors frame as the advantage of building in a market without decades of accumulated health IT. Documentation, decision support, and error detection are all inference; there is no legacy product underneath.
The position is stated explicitly and is notable given the company markets a suite it describes as AI healthcare employees including AI doctors and nurses: it supports clinicians rather than making decisions, with the physician always making the final call and retaining clinical responsibility. Error flagging in real time so the clinician can adjust course is decision support by design, since the system surfaces a concern rather than acting on it. Holding a clear ceiling while using employee framing in marketing is a distinction buyers should note, and here the ceiling is documented.
Unusually specific for a company one year old, with named sites and figures: protocol adherence reported rising from 84 percent to 99 percent, 1.7 to 2 hours recovered per physician daily, 60,000 errors flagged in real time, over 5 million consultations processed, and Mater Dei reporting roughly eight hours of daily use per physician. Sustained daily use at that intensity is a strong adoption signal because it is hard to fake. Held back from A because all figures are vendor or investor stated without published methodology, and the errors prevented count in particular needs a definition of what was counted and how prevention was established.
Better than most in this index because tier structure is public even though enterprise pricing is not: a free tier exists for independent private practice physicians, with hospital system agreements negotiated separately. Publishing a free entry point tells an individual clinician exactly what they can access without a sales conversation, which is the same practice that earned Freed a high grade. Held back from A because no institutional pricing is disclosed.
Deliberately scoped to Latin America and localized rather than translated: models are trained on local institutional protocols alongside clinical guidelines and peer reviewed literature, which is what makes protocol adherence measurement possible. Deployed across more than 25 hospital systems in Brazil, Colombia, and Mexico. A free tier for independent private practice physicians extends reach to clinicians outside institutional settings, which matters in a region the company cites as having 43 percent fewer physicians per capita than the OECD average.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Free tier for independent physicians; enterprise agreements for hospital systems
|
Free individual tier plus negotiated hospital system agreements | — | — | Vendor Published |
Tier structure is partially public, which is better than most enterprise vendors here. A free tier is offered to independent private practice physicians, explicitly aimed at clinicians without institutional technology access, while hospital system deployments are negotiated enterprise agreements with no published rate. Institutions should note the vendor frames value through time recovered per physician, roughly 1.7 to 2 hours daily, and protocol adherence improvement, so the business case is clinical capacity and quality rather than direct cost reduction.